Men and women with lower extremity peripheral arterial disease (PAD) have reduced physical activity levels compared with persons without PAD. We describe associations between physical activity levels with D-dimer, pro-coagulant factors, and inflammatory markers in patients with PAD. Participants were188 patients with PAD identified from non-invasive vascular laboratories. Physical activity was measured over 7 days with a vertical accelerometer. We measured the ankleÀbrachial index (ABI) and levels of D-dimer, C-reactive protein (CRP), fibrinogen, serum amyloid A (SAA), prothrombin 1.2, t-PA antigen, PAI-1, and the t-PA antigen=PAI-1 ratio. Adjusting for age, sex, race, body mass index, ABI, comorbidities, smoking, total cholesterol=HDL ratio and statin use (for CRP only), we found significant inverse linear associations between physical activity levels and log D-dimer (p ¼ 0.002), log CRP (p < 0.001), fibrinogen (p ¼ 0.014), and log SAA (p ¼ 0.012). There were no significant associations between physical activity levels and other blood factors. In an analysis adjusting for all blood factors simultaneously along with known and potential confounders, log D-dimer was the only blood factor associated significantly with physical activity levels (p ¼ 0.036). Based on these findings, future studies should assess whether interventions to increase physical activity in patients with PAD reduce levels of D-dimer and inflammatory markers.
Introduction
Increased levels of inflammatory markers and procoagulant circulating factors are associated with increased cardiovascular event rates. 1À5 In healthy communitydwelling men and women, recent studies also show associations of higher levels of inflammatory markers and pro-coagulant factors with faster functional decline and=or greater impairment in lower extremity functioning. 6, 7 The specific roles of circulating pro-coagulant and inflammatory markers in the development and progression of atherosclerosis are not fully defined. However, because higher levels of some inflammatory and hemostatic markers are associated with atherosclerotic progression and functional decline, 1À7 treatments to reduce levels of these markers may prevent cardiovascular events and functional decline. Among healthy individuals, initiation of an exercise program is associated with decline in inflammatory cytokine levels. 8 Men and women with lower extremity peripheral arterial disease (PAD) have lower physical activity and increased levels of D-dimer and some hemostatic factors than persons without PAD. 9À12 Associations between physical activity with these and other blood factors in PAD are not well defined. In this cross-sectional study, we hypothesized that higher levels of physical activity are associated with reduced concentrations of inflammatory and hemostatic markers. Our previous study shows that increased levels of D-dimer and to a lesser degree high-sensitivity C-reactive protein (CRP) are associated with impairment in objectively measured lower extremity functioning, as assessed by performance on the 6-min walk test and walking speed. 13 However, while performancebased measures assess maximum performance, these measures are distinct from typical activity levels during daily living.
Blood factors studied fell into three categories: inflammatory markers (high-sensitivity CRP, serum amyloid A (SAA), and fibrinogen), a marker of fibrinolysis (D-dimer), and pro-thrombotic factors (fibrinogen, prothrombin 1.2, tissue plasminogen activator antigen (tPA antigen), and plasminogen activator inhibitor-1 (PAI-1)). Rationale for studying associations between inflammatory markers and physical activity levels includes the fact that previous studies show increased levels of inflammation in association with reduced muscle mass, greater muscle catabolism, and impaired muscle repair. 14À17 Rationale for studying associations between D-dimer and physical activity includes a previous study showing that increased D-dimer levels are associated with greater PAD severity and lower ABI levels. 11 In addition, D-dimer influences inflammatory and acute-phase responses by promoting neutrophil and monocyte activation, inflammatory cytokine secretion, and hepatic production of acute-phase proteins. 18À21 Rationale for studying associations between physical activity and pro-thrombotic markers includes previous studies showing associations between exercise training and increased fibrinolysis in healthy populations and populations with coronary disease. 22À24 A study in patients with intermittent claudication shows that low levels of energy expenditure, but not moderate levels of energy expenditure, are associated with impaired fibrinolysis as compared with patients with high levels of energy expenditure. 25 However, in a separate study, submaximal exercise in PAD patients with intermittent claudication was associated with an acute increase in thrombin formation. 26 Thus, associations between exercise and pro-thrombotic markers in patients with PAD are unclear.
If greater physical activity levels are associated with lower levels of inflammatory factors, D-dimer, and prothrombotic factors, these findings would suggest that increasing physical activity in patients with PAD may result in lower levels of inflammatory markers, D-dimer, and pro-thrombotic factors that are associated with cardiovascular events and functional decline.
Methods

Participant identification
This study was performed among PAD patients aged 55 years and older participating in the Walking and Leg Circulation Study (WALCS), an observational study assessing the natural history of lower extremity functioning in patients with PAD. 9, 27 The study was Institutional Review Board-approved by Northwestern University's Feinberg School of Medicine and Catholic Health Partners Hospital. All participants gave informed consent.
The WALCS PAD participants were identified from among consecutive men and women aged 55 and older diagnosed with PAD in three Chicago-area non-invasive vascular laboratories. A small number were identified from among men and women aged 55 and older in Northwestern's largest general internal medicine practice. All participants had an ankleÀbrachial index (ABI) < 0.90. Characteristics of this study population have been described previously. 9 In the present study, all WALCS participants with PAD who wore the accelerometer for physical activity measurement and had blood drawn were included. A small number of WALCS participants with PAD did not have blood drawn, either because the participant refused or because phlebotomy was technically difficult and no blood was obtained ( Figure 1 ). In addition, we had an insufficient number of accelerometers available for all participants to wear them. Therefore, accelerometers were distributed to participants depending on whether they were available at the end of the study appointment. As a result, 47% of the potentially eligible study population wore them. We found no significant differences in patient characteristics between individuals who wore accelerometers versus those who did not wear accelerometers (Table 1) .
AnkleÀbrachial index measurement
After participants rested supine for 5 min, a hand-held Doppler probe (Nicolet Vascular Pocket Dop II, Golden, CO, USA) was used to measure systolic pressures in the right brachial artery, right dorsalis pedis and posterior tibial arteries, left dorsalis pedis and posterior tibial arteries, and left brachial artery. Pressures were measured twice: in the order listed and then in reverse order. ABIs were calculated by dividing average pressures in each leg by the average of the four brachial pressures, based on a previous study. 28 Average brachial pressures in the arm with the highest pressure were used when one brachial pressure was higher than the opposite brachial pressure in both measurement sets, and the two brachial pressures differed by 10 or more mmHg in at least one measurement set. In such cases subclavian stenosis was possible. The lowest leg ABI was used in all analyses.
Blood collection
A 21-gauge butterfly needle was inserted into a large antecubital vein and the tourniquet removed immediately. Blood was collected into EDTA and citrate vacutainer tubes and immediately iced. Tubes were spun at 3000 revolutions per min for 20 min at 4 C in a refrigerated centrifuge.
D-dimer levels
An Asserachrom D-Di kit (Diagnostica Stago, Asnieres-Sur-Seine, France) was used to measure fibrin D-dimer. The Asserachrom D-Di kit uses an enzyme-linked immunosorbent assay (ELISA) procedure to quantitatively determine D-dimer concentration.
Fibrinogen
Fibrinogen was measured by the method of Clauss using reagents from Hemoliance (Beckman Coulter Inc, Palatine, IL, USA). The assay was calibrated with standard normal plasma (Universal Coagulation Reference Plasma, Pacific Hemostasis) and the results calculated using the data management system of the MLA-Electra 800 clot timer.
PAI-1
PAI-1 was quantitated by an ELISA obtained from Biopool Inc (TintElize PAI-1; Trinity Biotech Distribution, Jamestown, NY, USA). A standard curve is constructed with the plasma standard provided by Biopool, and the results are reported in ng=ml plasma.
t-PA antigen t-PA antigen was measured by an ELISA obtained from Biopool. Test plasma or standards were added to microtest wells. The color developed was read in a microtest plate spectrophotometer at 492 nm and is proportional to the amount of t-PA present in the sample.
Prothrombin 1.2
This fragment was assayed using an ELISA method from Behring Diagnostics (Dade Behring, Newark, DE, USA).
Each well is filled with 50 ml of standard containing 0.04 nmol=l F 1.2, a control of known F 1.2 concentration, or sample. The measurement range is 0.04À10 nmol=l.
CRP levels CRP levels were determined using an immunotechnique on the Behring BN II analyzer (Dade Behring, Wilmingt on, DE, USA). Monoclonal anti-CRP antibodies, coated on polystyrene beads, agglutinate with CRP in the serum sample. The intensity of the resulting scattered light in the nephelometer was used to determine the CRP content. This assay detects CRP concentrations as low as 0.015 mg=dL. 29 SAA levels SAA levels were measured using an immunotechnique on the Behring BN II analyzer (Dade Behring). Polyclonal anti-SAA antibodies, which are coated on polystyrene 
Total cholesterol and HDL levels
Total cholesterol levels were measured using enzymatic reaction with peroxidase=phenol-4-aminophenazone indicator reaction. 30 The concentration of HDL-cholesterol was determined using a direct enzymatic colorimetric assay. 31 Accelerometer-measured physical activity Physical activity levels over 7 days were measured using the Caltrac vertical accelerometer (Torrance, CA, USA). This accelerometer is the size of a pager and is worn at the waist below the axilla. Accelerometers were programmed using identical weight, height, age, and sex for each participant so that activity levels could be compared specifically between all study participants. 9, 32 Programmed in this manner, the accelerometer measures 'activity units,' based on movement detected by the accelerometer. We previously validated the accelerometer in patients with PAD against the ABI and distance walked. 9, 32 Participants were asked to wear the accelerometer continuously for 7 days, removing them only for bathing or sleeping. Participants returned the accelerometers by mail.
Comorbidities
Algorithms developed for the Women's Health and Aging
Study and the Cardiovascular Health Study were used to document comorbidities. 33 These algorithms combine data from patient report, physical examination, medical record review, medications, laboratory values, and a primary care physician questionnaire. We grouped angina, myocardial infarction, stroke, and heart failure into a 'cardiac or cerebrovascular disease' category. We grouped knee arthritis, hip arthritis, hip fracture, spinal stenosis, and disk disease into an 'arthritis' category. Pulmonary disease and cancer were combined into an 'other' disease category.
Statin use
All prescription medications were recorded. The principal investigator (MMM) reviewed and classified medications according to whether or not they were statins. The principal investigator was blinded to all other participant data when medications were reviewed.
Other measurements
Body mass index Height and weight were measured at the study visit. Body mass index (BMI) was calculated as: weight(kg)=height 2 (m 2 ).
Cigarette smoking
History of cigarette smoking (total pack-years ever smoked) was determined with patient report.
Statistical analyses
To illustrate possible linear relationships between blood factor levels and physical activity, participants were categorized into quintiles according to their physical activity level: quintile 1: < 443 activity units; quintile 2: 443 to < 634 activity units; quintile 3: 634 to < 813 activity units; quintile 4: 813 to < 1058 activity units; quintile 5: ! 1058 activity units. Mean blood factor levels and other patient characteristics were compared between the physical activity quintiles using general linear models, adjusting for age. For continuous variables, the tests for linear trend across the physical activity quintiles were based on general linear models using the actual physical activity level as an independent variable. Proportions for dichotomous variables were estimated using general linear models and the test for linear trend was based on ageadjusted logistic models. Mean blood factor levels and other patient characteristics were next compared between the physical activity quintiles using general linear models, adjusting for age, race, sex, BMI, ABI, cigarette smoking (pack-years), total cholesterol=HDL ratio, and comorbidities. Because statin drugs lower CRP levels, mean CRP levels across the physical activity categories were adjusted for statin use (yes À using statins=no À not using statins). We assessed associations between the ratio of t-PA antigen to PAI-1 and physical activity quintiles, based on previous data demonstrating that the physiological equilibrium between tPA and PAI-1 may be a more sensitive determinant of future clinically evident atherosclerosis than individual levels of tPA and PAI-1. 34À38 Because the distribution of D-dimer, CRP, and SAA were skewed, natural-log transformed values were used in analyses for these blood factors.
Multivariable regression analysis was performed to determine associations between physical activity level and 
Results
Participants were 188 men and women with PAD. Lower quintiles of physical activity were associated with older age (p-trend ¼ 0.002). Table 2 shows age-adjusted characteristics of the study population according to physical activity quintile. Participants with lower physical activity levels had significantly lower ABI and HDL cholesterol levels, included a higher proportion of African Americans, and had a significantly greater number of cardiac or cerebrovascular diseases. We found no significant associations between physical activity and sex, BMI, smoking, total cholesterol, diabetes, number of arthritis comorbidities, or number of other comorbid diseases. In age-adjusted analyses, lower physical activity quintiles were associated linearly and significantly with higher levels of D-dimer, CRP, fibrinogen, SAA, and PAI-1, but not with prothrombin 1.2, t-PA antigen, or the t-PA=PAI-1 ratio ( Table 2) . Table 3 shows associations between blood factor levels and physical activity quintiles, adjusting for age, sex, race, ABI, BMI, comorbid diseases, cigarette smoking, and cholesterol levels. CRP analyses also adjusted for statin use. Inverse, significant associations remained between physical activity quintiles and levels of D-dimer, CRP, fibrinogen, and SAA. No significant associations were observed between the remaining blood factors and physical activity quintile after the additional adjustments.
To verify whether relationships between D-dimer, fibrinogen, CRP, and SAA and physical activity are expressions of the same underlying biological mechanisms, we tested whether associations between each blood factor and physical activity were maintained after adjusting for the other blood factors, again adjusting for known and potential confounders. As shown in Figure 2 , the adjusted associations between D-dimer and CRP with physical activity shown in Table 2 were attenuated somewhat after additional adjustment for the other blood factors. However, the relationship between D-dimer and physical activity levels remained statistically significant (p ¼ 0.036). There was a trend in the relationship between CRP and physical activity levels, but after adjustment for other blood factors the association was reduced to borderline statistical significance ðp ¼ 0.059). p-values derived from tests for trend using general linear models for continuous variables, and logistic models for dichotomous variables. Cardiac or cerebrovascular disease was defined as one or more of the following: history of myocardial infarction, heart failure, angina, stroke. Arthritis was defined as one or more of the following: knee arthritis, hip arthritis, hip fracture, spinal stenosis, or disk disease. Other comorbid diseases included pulmonary disease and cancer. HDL, high-density lipoprotein; t-PA, tissue-type plasminogen activator antigen; PAI-1, plasminogen activator inhibitor.
Discussion
In this cross-sectional study of men and women with PAD, we found inverse relationships between physical activity levels with D-dimer and three markers of inflammation (CRP, fibrinogen, and SAA), after adjustment for known and potential confounders. The relationship between reduced physical activity levels with higher D-dimer levels persisted after additional adjustment for the other blood factor levels, indicating a particularly robust association between D-dimer and physical activity in patients with PAD. Pro-coagulant and inflammatory markers have been implicated in the pathogenesis of atherosclerosis, and increased levels are associated with higher rates of cardiovascular morbidity and mortality. 1À5 Higher levels of procoagulant and inflammatory markers are also associated with greater functional impairment and functional decline. 6, 39, 40 We previously reported associations between increased levels of D-dimer and CRP with poorer performance on objective measures of functioning in persons with and without PAD. 13 In contrast to data reported here, our previous work did not find significant associations between SAA or fibrinogen with objective measures of functioning after adjusting for confounders. To our knowledge, no prior studies have simultaneously assessed associations between D-dimer, inflammatory markers, or prothrombotic factors with 7-day physical activity levels in persons with PAD.
Of all the blood factors studied here, only D-dimer remained independently associated with physical activity after adjusting for the other inflammatory markers and pro-coagulant factors. One potential explanation for this finding is that physical activity levels influence the overall burden of atherosclerosis, which is reflected by D-dimer, a measure of ongoing thrombus formation and fibrinolysis. However, D-dimer also influences inflammatory and acute-phase responses by promoting neutrophil and monocyte activation, inducing secretion of inflammatory cytokines, and promoting hepatic synthesis of acute-phase proteins. 19À21,41 Previously, inflammatory states have been associated with sarcopenia, an age-related reduction in muscle mass and strength. 14,15,42À44 If inflammatory states weaken muscles, this could lead to lower physical activity levels and may explain the inverse associations we observed between inflammatory markers and physical activity levels.
Together, data reported here suggest that among persons with PAD, increased daily physical activity levels are associated with lower levels of blood factors related to the inflammatory process but not with lower levels of pro-thrombotic factors. Many prior studies linking increased levels of physical activity to lower levels of pro-thrombotic factors have been conducted in patients who are generally healthy without clinically evident atherosclerotic disease. 45 Since patients with PAD typically have lower physical activity than patients without PAD, the highest levels of activity observed in patients with PAD may be insufficient to reduce pro-thrombotic markers. Alternatively, among patients with clinically recognized PAD similar to those participating in the present study, levels of pro-thrombotic blood factors may be less susceptible to change as a result of physical activity levels than inflammatory factors. A previous study demonstrated that submaximal treadmill exercise induced acute thrombin formation in patients with PAD but not in patients without PAD, 26 suggesting that associations between physical exertion may differ between patients with versus without PAD.
A large body of cross-sectional data documents that higher levels of long-term physical activity are associated with lower levels of fibrinogen and pro-coagulant factors. 45À49 Higher physical activity levels have also been associated with lower CRP levels. 50 Furthermore, clinical trials in healthy individuals and patients with coronary artery disease have demonstrated that exercise is associated with reductions in fibrinogen and pro-coagulant factors. 51, 52 In an uncontrolled clinical trial of 23 healthy Table 3 Mean blood factor levels among men and women aged 55 and older with peripheral arterial disease according to the 7-day physical activity quintile (n ¼ 188 men, 6 months of endurance training was associated with a 39% reduction in tPA antigen in the 13 older male participants (aged 60À81), but no change among the 10 younger men (aged 24À30 years). 52 Previous studies have also demonstrated acute increases in fibrinogen and thrombin generation and decreases in fibrinolytic activity in response to acute exercise. 53À55 Our findings add to previous work on specific blood factors and typical daily physical activity in PAD patients who have been shown previously to have significantly reduced levels of physical activity as well as higher levels of D-dimer, pro-coagulant factors and inflammatory markers compared with patients without PAD. 9, 32 Although we observed inverse, highly significant relationships between the number of cardiovascular comorbid diseases, the ABI, and physical activity, we did not observe associations between the number of arthritis comorbidities or the number of 'other' comorbidities with physical activity levels. Lack of associations between these latter comorbid diseases and physical activity may be due to the relatively low physical activity levels typically observed in patients with PAD and=or the importance of the ABI and prevalent cardiac and cerebrovascular comorbidities as determinants of physical activity in this population.
Although not an aim of the present study, it is conceivable that associations between ABI, cardiac comorbidities, and Figure 2 Adjusted mean blood factor levels among men and women aged 55 and older with peripheral arterial disease according to 7-day physical activity quintiles (n ¼ 188). (Physical activity quintiles (activity units): 1 ¼ 62 < 438, 2 ¼ 438 < 628, 3 ¼ 628 < 807, 4 ¼ 807 < 1055, 5 ¼ 1055À3225. Partially adjusted values adjust for age, sex, race, BMI, ABI, smoking, and comorbidities. Fully adjusted values adjust for age, sex, race, BMI, ABI, smoking, comorbidities and other blood factors. CRP analyses also adjusted for statin use).
Vascular Medicine 2004; 9: 107-115 cerebrovascular comorbidities override any associations between arthritis comorbidities or other comorbidities with physical activity levels in patients with PAD.
Our study is limited by the fact that just 47% of eligible PAD participants wore the accelerometer. However, characteristics were similar between participants who wore the accelerometer versus those who did not wear the accelerometer. Another study limitation is that the direction of the causal pathway linking the blood factors studied here to reduced physical activity cannot be determined in this cross-sectional study. Thirdly, study participants were referred from non-invasive vascular laboratories at several medical centers. Findings may not be generalizable to persons with PAD identified from other settings, such as recruited from a community setting.
Based on findings reported here, future studies should assess whether interventions to increase physical activity in patients with PAD reduce levels of D-dimer and inflammatory markers. Future study is also indicated to determine whether reducing levels of D-dimer and inflammation factors in patients with PAD may decrease both functional decline and cardiovascular event rates.
